Celldex Therapeutics logo
Celldex Therapeutics
CLDX | NASDAQ
Chart Builder DCF Calculator
$28.59
-$0.24 (-0.83%)
At close: Nov 16, 2026, 4:00 PM ET
$28.02
-$0.57 (-1.98%)
Pre-market: Nov 17, 2026, 4:05 AM ET

Celldex Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Quarter
Period Ending
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Q2 2024
Jun 30, 2024
Q1 2024
Mar 31, 2024
Q4 2023
Dec 31, 2023
Q3 2023
Sep 30, 2023
Q2 2023
Jun 30, 2023
Q1 2023
Mar 31, 2023
Q4 2022
Dec 31, 2022
Q3 2022
Sep 30, 2022
Q2 2022
Jun 30, 2022
Q1 2022
Mar 31, 2022
Q4 2021
Dec 31, 2021
Q3 2021
Sep 30, 2021
Q2 2021
Jun 30, 2021
Q1 2021
Mar 31, 2021
-75.56M -73.5M -78.69M -81.32M -67.04M -56.6M -53.8M -47.09M -42.12M -35.84M -32.81M -43.31M -38.26M -30.5M -29.36M -26.49M -26.78M -36M -23.05M -20.15M -20.45M -13.37M -16.54M
1.16M 902K 854K 816K 824K 873K 867K 819K 786K 797K 775K 759K 767K 756K 726K 673K 671K 741K 811K 777K 752K 764K 775K
10.97M 8.41M 8.52M 8.91M 8.8M 9.19M 9.32M 9.78M 9.62M 7.64M 7.2M 7.21M 7.12M 5.22M 4.34M 4.51M 4.5M 3.45M 3.15M 3.14M 3.03M 1.51M 1.28M
76K -1.66M 2.85M 5.86M -3.26M 1.16M 586K -770K -26.68M -33K -7.68M 3.48M 4.66M -3.18M 1.4M -2.18M -15.07M 13.28M -2.88M -165K -590K -2.81M -2.71M
-742K -1.7M -627K -882K -1.01M -1.69M -2.26M -3.36M -4.33M -4.74M -3.31M -42.07M 38.26M -1.16M -1.26M -521K 2K -5.73M 236K -48K -1.63M 133K 411K
– – – – – – – – – – – 39.89M -39.89M – – – – – – – -227K – –
-872K 8.48M 4.35M 8.53M 9.8M 4.22M -8.5M 7.38M -19.29M 2.82M -12.5M 4.98M 13.01M -1.51M -3.02M 65K -13.58M 15.3M -5.68M 1.76M 2.16M -963K -4.01M
-65.04M -57.41M -65.59M -63.94M -48.63M -44.01M -54.37M -32.48M -55.34M -29.33M -40.64M -32.53M -18.99M -27.2M -28.57M -21.76M -35.19M -22.24M -24.53M -14.52M -16.37M -11.93M -18.08M
-1.67M -3.18M -1.64M -993K -440K -728K -265K -756K 618K -274K -344K -666K -157K -410K -585K -235K -345K -673K -575K -354K -185K -143K -567K
– – – – – – – – – – – -585K -11.8M – – – 69K – – 2K 1K – 24K
-62.21M -402.85M -59.61M -54.79M -55.63M -122.26M -151.82M -129.18M -100.06M -168.51M -392.18M -241.39M -27.75M -81.58M -73.85M -56.35M -62.77M -52.96M -16.89M -64.54M -239.6M -51.77M -33.97M
107.29M 150.51M 133.37M 111.5M 116.92M 172.84M 195.04M 153.98M 148.36M 122.06M 77.31M 70.89M 39.55M 83.15M 127M 87.8M 86.11M 78.91M 27.85M 45.95M 13M 38M 78M
– – – -288K – – – – -1.16M – – 585K 11.8M – – – – – – – – – –
43.42M -255.52M 72.12M 55.43M 60.85M 49.85M 42.95M 24.05M 47.76M -46.72M -315.21M -171.16M 11.65M 1.16M 52.57M 31.21M 23.07M 25.28M 10.38M -18.94M -226.79M -13.91M 43.49M
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – –
– – – – – – – – – – 3.81M – – – – – – – – – 2M – –
1.12M 324.66M 327K 1.35M 774K 63K 202K 386K 1.24M 3.71M 436.11M 217.37M 257K 133K 694K 1.4M 2.31M 71K 304K 426K 271.9M -25K 74K
-20.5M 11.73M 6.86M -7.17M 12.99M 5.91M -11.22M -8.04M -6.34M -72.34M 80.26M 13.68M -7.09M -25.9M 24.69M 10.85M -9.82M 3.11M -13.85M -33.04M 28.74M -25.87M 25.48M
-66.7M -60.59M -67.23M -64.93M -49.07M -44.73M -54.64M -33.23M -54.72M -29.6M -40.98M -33.2M -19.15M -27.61M -29.15M -22M -35.54M -22.92M -25.11M -14.88M -16.56M -12.07M -18.65M
-77.68M -69M -75.75M -73.84M -57.87M -53.92M -63.95M -43.01M -64.34M -37.24M -48.18M -40.41M -26.27M -32.82M -33.49M -26.51M -40.03M -26.37M -28.26M -18.02M -19.59M -13.58M -19.93M
-1.16M -902K -854K -993K -440K -728K – -756K 1.24M – -344K – – -293.88K – – -28.15K -673K -575K -354K -185K – -567K
-505K -2.28M -785K – – – -265K – -618K -274K – -666K -157K -116.12K -585K -235K -316.85K – – – – -143K –
-66.2M -58.31M -66.44M -64.93M -49.07M -44.73M -54.37M -33.23M -54.1M -29.33M -40.98M -32.53M -18.99M -27.49M -28.57M -21.76M -35.22M -22.92M -25.11M -14.88M -16.56M -11.93M -18.65M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.